Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,603 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $456.02 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $449.94 | 13 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $424.71 | 12 | $0 (2023) |
| GENZYME CORPORATION | $352.76 | 5 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $249.73 | 2 | $0 (2024) |
| PFIZER INC. | $104.51 | 1 | $0 (2017) |
| CSL Behring | $99.99 | 1 | $0 (2017) |
| OptiNose US, Inc. | $99.66 | 1 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $83.04 | 4 | $0 (2021) |
| Allergan, Inc. | $48.02 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $488.45 | 8 | Phathom Pharmaceuticals, Inc. ($249.73) |
| 2023 | $321.97 | 8 | GlaxoSmithKline, LLC. ($250.32) |
| 2022 | $258.85 | 13 | Regeneron Healthcare Solutions, Inc. ($98.03) |
| 2021 | $204.09 | 10 | Biohaven Pharmaceuticals, Inc. ($69.74) |
| 2020 | $110.35 | 6 | Allergan, Inc. ($48.02) |
| 2019 | $380.35 | 8 | GlaxoSmithKline, LLC. ($129.43) |
| 2018 | $274.77 | 7 | AstraZeneca Pharmaceuticals LP ($133.83) |
| 2017 | $564.66 | 8 | GENZYME CORPORATION ($206.46) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Immunology | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Respiratory | ||||||
| 04/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $46.38 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 07/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $120.84 | General |
| 05/12/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Neurology | ||||||
| 04/04/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/24/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: IMMUNOLOGY | ||||||
| 02/01/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $100.77 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/29/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/13/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/16/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Immunology | ||||||
| 07/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: PRIMARY CARE | ||||||
| 07/12/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 06/07/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/03/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 70 | 311 | $10,149 | $3,903 |
| 2022 | 5 | 246 | 997 | $45,142 | $23,404 |
| 2021 | 5 | 297 | 984 | $46,459 | $26,509 |
| 2020 | 9 | 247 | 1,647 | $44,569 | $22,858 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 31 | 270 | $4,860 | $2,084 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 41 | $5,289 | $1,819 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 140 | $18,060 | $10,937 | 60.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 41 | 720 | $12,960 | $6,653 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 73 | $6,570 | $3,043 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $6,837 | $2,519 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $715.00 | $251.80 | 35.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 112 | 112 | $14,508 | $8,179 | 56.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 44 | 678 | $12,294 | $6,901 | 56.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 66 | $8,334 | $5,497 | 66.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 114 | $10,155 | $5,381 | 53.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $1,168 | $552.18 | 47.3% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 62 | 960 | $17,280 | $8,519 | 49.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 98 | $10,682 | $6,119 | 57.3% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 12 | 448 | $6,750 | $2,657 | 39.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 50 | $3,700 | $2,201 | 59.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $2,580 | $1,383 | 53.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 17 | 17 | $1,462 | $858.75 | 58.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 21 | $1,050 | $548.51 | 52.2% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 16 | 16 | $640.00 | $306.72 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $425.00 | $265.23 | 62.4% |
About Dr. Frank Simon, MD
Dr. Frank Simon, MD is a Allergy & Immunology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336147065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Simon, MD has received a total of $2,603 in payments from pharmaceutical and medical device companies, with $488.45 received in 2024. These payments were reported across 68 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,603).
As a Medicare-enrolled provider, Simon has provided services to 860 Medicare beneficiaries, totaling 3,939 services with total Medicare billing of $76,674. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Louisville, KY
- Active Since 07/07/2005
- Last Updated 01/15/2008
- Taxonomy Code 207RA0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336147065
Products in Payments
- DUPIXENT (Biological) $458.14
- NUCALA (Biological) $275.04
- VOQUEZNA (Drug) $249.73
- ATOPIC DERMATITIS - DISEASE (Drug) $206.46
- FASENRA (Drug) $139.10
- EUCRISA (Drug) $104.51
- Hizentra (Biological) $99.99
- Xhance (Drug) $99.66
- DUPIXENT DUPILUMAB INJECTION (Biological) $97.91
- FASENRA (Biological) $95.80
- NURTEC ODT (Drug) $95.43
- UBRELVY (Drug) $73.42
- TRELEGY ELLIPTA (Drug) $54.06
- AIRSUPRA (Drug) $46.38
- TOSYMRA (Drug) $44.41
- Xolair (Biological) $25.41
- PALFORZIA (Biological) $24.26
- CUVITRU (Biological) $19.24
- NIOX VERO (Device) $18.80
- Trudhesa (Drug) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Louisville
James Sublett, M.d, M.D
Allergy & Immunology — Payments: $540,567
Stephen Pollard, M.d, M.D
Allergy & Immunology — Payments: $322,437
Douglas Lotz, M.d, M.D
Allergy & Immunology — Payments: $212,066
Dr. Mark Corbett, M.d, M.D
Allergy & Immunology — Payments: $154,857
Dr. Jeremy Jones, Md, MD
Allergy & Immunology — Payments: $152,692
David Pallares, M.d, M.D
Allergy & Immunology — Payments: $23,211